IL-2 based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis. J Immunol Jablons D, Bolton E, Mertins S, Rubin M, Pizzo PA, Rosenberg SA, Lotze MT 1990; 144: 3630--6